[1]
J. Lazić, “Importance of pharmacogenetic markers in the methylenetetrahydrofolate reductase gene during methotrexate treatment in pediatric patients with acute lymphoblastic leukemia”, Arch Biol Sci, vol. 69, no. 2, pp. 239–246, May 2017.